Domov › Burkitov lymfóm › Ohio › Cincinnati
Klinické štúdie Burkitov lymfóm v meste Cincinnati, OH
12 štúdií pre Burkitov lymfóm hľadá účastníkov v zariadeniach v meste Cincinnati a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Prebieha náborFáza 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Prebieha náborFáza 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 míľ odtiaľ
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Prebieha náborObservačná štúdia
- Cincinnati Children's Hospital Medical Center, Cincinnati
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
Prebieha náborFáza 2
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 míľ odtiaľ
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Prebieha náborFáza 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Prebieha náborFáza 3
- University of Cincinnati Medical Center, Cincinnati
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
Prebieha náborFáza 3
- Cincinnati Children's Hospital Medical Center (Data Collection Only), Cincinnati
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Prebieha náborFáza 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Prebieha náborFáza 3
- Cincinnati Children's Hospital Medical Center, Cincinnati
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Prebieha náborFáza 2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
Prebieha náborFáza 1
- Cincinnati Children's Hospital Medical Center, Cincinnati
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Prebieha náborFáza 1
- University of Cincinnati, Cincinnati
Štúdie Burkitov lymfóm v iných mestách
- Houston, TX21 štúdií
- Milwaukee, WI16 štúdií
- Philadelphia, PA16 štúdií
- New York City, NY14 štúdií
- Chicago, IL14 štúdií
- Atlanta, GA12 štúdií
- Seattle, WA11 štúdií
- Boston, MA10 štúdií
- Durham, NC10 štúdií
- Aurora, CO10 štúdií
- Los Angeles, CA10 štúdií
- Kansas City, MO10 štúdií
Iné štúdie v Cincinnati
- Nemalobunkový karcinóm pľúc35 štúdií
- Rakovina (všetky typy)27 štúdií
- Rakovina prsníka25 štúdií
- Srdcové zlyhanie24 štúdií
- Kolorektálny karcinóm21 štúdií
- Akútna myeloidná leukémia20 štúdií
- Metastatická rakovina20 štúdií
- Rakovina vaječníkov19 štúdií
- Rakovina pľúc19 štúdií
- Obézita19 štúdií
- Rakovina prostaty18 štúdií
- Mnohonásobný myelóm17 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.